Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2014, Article ID 512928, 4 pages
http://dx.doi.org/10.1155/2014/512928
Case Report

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm

Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Dabrowskiego 25, 40-032 Katowice, Poland

Received 13 January 2014; Revised 30 July 2014; Accepted 13 August 2014; Published 2 September 2014

Academic Editor: Francesca Micci

Copyright © 2014 Patrycja Zielinska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Berg, “The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma,” Journal of the National Cancer Institute, vol. 38, no. 5, pp. 741–752, 1967. View at Google Scholar · View at Scopus
  2. M. M. Bartik, D. Welker, and N. E. Kay, “Impairments in immune cell function in B cell chronic lymphocytic leukemia,” Seminars in Oncology, vol. 25, no. 1, pp. 27–33, 1998. View at Google Scholar · View at Scopus
  3. L. Laurenti, M. Tarnani, I. Nichele et al., “The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience,” The American Journal of Hematology, vol. 86, no. 12, pp. 1007–1012, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Vannucchi, G. Masala, E. Antonioli et al., “Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 7, pp. 2068–2073, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Gargallo, R. Cacchione, C. Chena et al., “Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events,” Cancer Genetics and Cytogenetics, vol. 161, no. 1, pp. 74–77, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Tabaczewski, S. Nadesan, and S. H. Lim, “Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?” Leukemia Research, vol. 33, no. 6, pp. 854–855, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Greene, R. N. Hoover, and J. F. Fraumeni Jr., “Subsequent cancer in patients with chronic lymphocytic leukemia: a possible immunologic mechanism,” Journal of the National Cancer Institute, vol. 61, no. 2, pp. 337–340, 1978. View at Google Scholar · View at Scopus
  8. A. Kimura, H. Hyodo, Y. Nakata, and A. Kuramoto, “Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1α in the pathogenesis,” The American Journal of Hematology, vol. 43, no. 1, pp. 47–50, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Spivak and R. T. Silver, “The revised world health organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal,” Blood, vol. 112, no. 2, pp. 231–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Hallek, B. D. Cheson, D. Catovsky et al., “Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines,” Blood, vol. 111, no. 12, pp. 5446–5456, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Palta, S. Garg, S. Chauhan, and N. Varma, “Simultaneous presence of two hematological malignancies: Chronic lymphocytic leukemia and myelofibrosis in a patient,” Indian Journal of Hematology and Blood Transfusion, vol. 27, no. 1, pp. 33–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Bhagavathi, V. Borromeo, H. Desai, and D. Crisan, “Case report and literature review: a rare patient with chronic myeloid leukemia and chronic lymphocytic leukemia,” Annals of Clinical and Laboratory Science, vol. 38, no. 4, pp. 405–409, 2008. View at Google Scholar · View at Scopus
  13. R. Chintapatla, R. Battini, and P. H. Wiernik, “Chronic lymphocytic leukemia with essential thrombocythemia: asbestos exposure association?” Clinical Advances in Hematology and Oncology, vol. 10, no. 11, pp. 752–755, 2012. View at Google Scholar · View at Scopus
  14. L. Aquino-Esquadro, S. Mehendale, S. Kadkol, D. Rondelli, and S. Gaitonde, “JAK2 V617F positive essential thrombocythemia complicated by B-cell chronic lymphocytic leukemia: an uncommon association and diagnostic pitfall,” Laboratory Medicine, vol. 42, no. 2, pp. 83–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Robak, H. Urbańska-Ryś, J. Góra-Tybor et al., “Coexistence of chronic lymphocytic leukemia and essential thrombocythemia,” Leukemia & Lymphoma, vol. 44, no. 8, pp. 1425–1431, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Manoharan, D. Catovsky, P. Clein et al., “Simultaneous or spontaneous occurrence of lympho- and myeloproliferative disorders: a report of four cases,” British Journal of Haematology, vol. 48, no. 1, pp. 111–116, 1981. View at Google Scholar · View at Scopus
  17. J. B. Gaillard, L. Henry, E. Jourdan, and T. Lavabre-Bertrand, “Association of myeloproliferative and lymphoproliferative disorders,” Clinical Advances in Hematology and Oncology, vol. 10, no. 11, pp. 756–757, 2012. View at Google Scholar · View at Scopus
  18. S. Burgstaller, S. Wimmer, B. Mayrbaeurl, W. Hoebling, and J. Thaler, “Coexistence of primary myelofibrosis and chronic lymphocytic leukaemia: treatment of two different diseases with one agent,” Blood Cancer Journal, vol. 1, no. 5, article e20, 2011. View at Publisher · View at Google Scholar · View at Scopus